These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 22456644)

  • 1. Endovascular treatment of in-stent restenosis using excimer laser angioplasty and drug eluting balloons.
    Van Den Berg JC; Pedrotti M; Canevascini R; Chimchila Chevili S; Giovannacci L; Rosso R
    J Cardiovasc Surg (Torino); 2012 Apr; 53(2):215-22. PubMed ID: 22456644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-stent restenosis: mid-term results of debulking using excimer laser and drug-eluting balloons: sustained benefit?
    van den Berg JC; Pedrotti M; Canevascini R; Chimchila Chevili S; Giovannacci L; Rosso R
    J Invasive Cardiol; 2014 Jul; 26(7):333-7. PubMed ID: 24993991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The combined use of Drug-eluting balloon and Excimer laser for coronary artery Restenosis In-Stent Treatment: The DERIST study.
    Ambrosini V; Golino L; Niccoli G; Roberto M; Lisanti P; Ceravolo R; Bernardi G; Armigliato P; Gabrielli G; Chizzola G; De Paulis C; Crea F; Colombo A
    Cardiovasc Revasc Med; 2017; 18(3):165-168. PubMed ID: 28081977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term results of drug-eluting balloon angioplasty for treatment of refractory recurrent carotid in-stent restenosis.
    Gandini R; Del Giudice C; Da Ros V; Sallustio F; Altobelli S; D'Onofrio A; Abrignani S; Vasili E; Stanzione P; Simonetti G
    J Endovasc Ther; 2014 Oct; 21(5):671-7. PubMed ID: 25290795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of various percutaneous interventions for in-stent restenosis: comprehensive network meta-analysis of randomized controlled trials.
    Sethi A; Malhotra G; Singh S; Singh PP; Khosla S
    Circ Cardiovasc Interv; 2015 Nov; 8(11):e002778. PubMed ID: 26546577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-eluting balloon in peripheral intervention for below the knee angioplasty evaluation (DEBATE-BTK): a randomized trial in diabetic patients with critical limb ischemia.
    Liistro F; Porto I; Angioli P; Grotti S; Ricci L; Ducci K; Falsini G; Ventoruzzo G; Turini F; Bellandi G; Bolognese L
    Circulation; 2013 Aug; 128(6):615-21. PubMed ID: 23797811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of laser atherectomy for the management of in-stent restenosis in the peripheral arteries.
    Jayasuriya S; Ward C; Mena-Hurtado C
    J Cardiovasc Surg (Torino); 2014 Jun; 55(3):339-45. PubMed ID: 24755702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment strategies for in-stent restenosis in peripheral arterial disease: a systematic review.
    Hajibandeh S; Hajibandeh S; Antoniou SA; Torella F; Antoniou GA
    Interact Cardiovasc Thorac Surg; 2019 Feb; 28(2):253-261. PubMed ID: 30052955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The endovascular approach for in-stent restenosis in femoropopliteal disease.
    Cannavale A; Tsetis D; Krokidis M
    Expert Rev Cardiovasc Ther; 2015 Apr; 13(4):391-401. PubMed ID: 25761905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Below-the-knee drug-eluting stents and drug-coated balloons.
    Karnabatidis D; Spiliopoulos S; Katsanos K; Siablis D
    Expert Rev Med Devices; 2012 Jan; 9(1):85-94. PubMed ID: 22145843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multicenter randomized comparison of paclitaxel-coated balloon catheter with conventional balloon angioplasty in patients with bare-metal stent restenosis and drug-eluting stent restenosis.
    Habara S; Iwabuchi M; Inoue N; Nakamura S; Asano R; Nanto S; Hayashi Y; Shiode N; Saito S; Ikari Y; Kimura T; Hosokawa J; Nakamura M; Kotani J; Kozuma K; Mitsudo K
    Am Heart J; 2013 Sep; 166(3):527-33. PubMed ID: 24016503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, multicenter, single-blinded trial comparing paclitaxel-coated balloon angioplasty with plain balloon angioplasty in drug-eluting stent restenosis: the PEPCAD-DES study.
    Rittger H; Brachmann J; Sinha AM; Waliszewski M; Ohlow M; Brugger A; Thiele H; Birkemeyer R; Kurowski V; Breithardt OA; Schmidt M; Zimmermann S; Lonke S; von Cranach M; Nguyen TV; Daniel WG; Wöhrle J
    J Am Coll Cardiol; 2012 Apr; 59(15):1377-82. PubMed ID: 22386286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-Term Outcomes After Treatment With a Paclitaxel-Coated Balloon Versus Balloon Angioplasty: Insights From the PEPCAD-DES Study (Treatment of Drug-eluting Stent [DES] In-Stent Restenosis With SeQuent Please Paclitaxel-Coated Percutaneous Transluminal Coronary Angioplasty [PTCA] Catheter).
    Rittger H; Waliszewski M; Brachmann J; Hohenforst-Schmidt W; Ohlow M; Brugger A; Thiele H; Birkemeyer R; Kurowski V; Schlundt C; Zimmermann S; Lonke S; von Cranach M; Markovic S; Daniel WG; Achenbach S; Wöhrle J
    JACC Cardiovasc Interv; 2015 Nov; 8(13):1695-700. PubMed ID: 26476609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of distal/bifurcation left main restenosis after drug eluting stents implantation: single center experience.
    Rigatelli G; Cardaioli P; Dell'Avvocata F; Giordan M; Vassilev D; Fraccaro C; Roncon L; Faggian G
    Cardiovasc Revasc Med; 2014 Mar; 15(2):76-9. PubMed ID: 24560299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does endovascular treatment of infra-inguinal arterial disease with drug-eluting stents offer better results than angioplasty with or without bare metal stents?
    Antoniou GA; Georgakarakos EI; Antoniou SA; Georgiadis GS
    Interact Cardiovasc Thorac Surg; 2014 Aug; 19(2):282-5. PubMed ID: 24729201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of cutting balloon angioplasty for pulmonary vein in-stent stenosis.
    Cook AL; Prieto LR; Delaney JW; Rhodes JF
    Am J Cardiol; 2006 Aug; 98(3):407-10. PubMed ID: 16860033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Superiority of stent-grafts for in-stent restenosis in the superficial femoral artery: twelve-month results from a multicenter randomized trial.
    Bosiers M; Deloose K; Callaert J; Verbist J; Hendriks J; Lauwers P; Schroë H; Lansink W; Scheinert D; Schmidt A; Zeller T; Beschorner U; Noory E; Torsello G; Austermann M; Peeters P
    J Endovasc Ther; 2015 Feb; 22(1):1-10. PubMed ID: 25775672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial.
    Kastrati A; Mehilli J; von Beckerath N; Dibra A; Hausleiter J; Pache J; Schühlen H; Schmitt C; Dirschinger J; Schömig A;
    JAMA; 2005 Jan; 293(2):165-71. PubMed ID: 15644543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictor of subsequent target lesion revascularization in patients with drug-eluting stent restenosis undergoing percutaneous coronary intervention.
    Takasawa Y; Iijima R; Shiba M; Nakamura M; Sugi K
    J Cardiol; 2010 May; 55(3):391-6. PubMed ID: 20350511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of Paclitaxel-Coated Balloon Catheter Dilation to Reduce In-Stent Restenosis in Transjugular Intrahepatic Portosystemic Shunt (TIPS).
    Marticorena Garcia SR; Langmann M; Schnorr B; Günther RW; Hamm B; Althoff CE
    Rofo; 2016 Apr; 188(4):374-80. PubMed ID: 27002498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.